tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Humacyte (HUMA)
NASDAQ:HUMA
US Market
HUMA
Humacyte
RESEARCH TOOLSreports

Humacyte (HUMA) Stock News & Sentiment

Compare
1,507 Followers
Humacyte Enters Sales Agreement with TD Securities
Premium
Company Announcements
Humacyte Enters Sales Agreement with TD Securities
10d ago
8K
HUMA
Humacyte Secures $77.5 Million Loan Facility
Premium
Company Announcements
Humacyte Secures $77.5 Million Loan Facility
11d ago
8K
HUMA
Humacyte Terminates Revenue Interest Agreement
Premium
Company Announcements
Humacyte Terminates Revenue Interest Agreement
11d ago
8K
HUMA
Buy Rating on Humacyte Driven by Promising Clinical Data and Strong Growth Prospects
Premium
Ratings
Buy Rating on Humacyte Driven by Promising Clinical Data and Strong Growth Prospects
25d ago
HUMA
Humacyte Ends Sale Agreement with Jefferies LLC
Premium
Company Announcements
Humacyte Ends Sale Agreement with Jefferies LLC
30d ago
8K
HUMA
Humacyte’s Promising Growth in Vascular Therapy Market Justifies Buy Rating
Premium
Ratings
Humacyte’s Promising Growth in Vascular Therapy Market Justifies Buy Rating
1M ago
HUMA
Positive Growth Prospects and Financial Stability Drive Buy Rating for Humacyte
Premium
Ratings
Positive Growth Prospects and Financial Stability Drive Buy Rating for Humacyte
1M ago
HUMA
More HUMA News >

HUMA News on the Web

Why Humacyte, Inc.’s (HUMA) Stock Is Down 5.31%
AAII
Neutral
Analysts’ Top Healthcare Picks: Schrodinger (SDGR), Humacyte (HUMA)
TipRanks News
Neutral
Why Humacyte, Inc.’s (HUMA) Stock Is Up 7.01%
AAII
Neutral
Humacyte Enters Sales Agreement with TD Securities
TipRanks News
Neutral
Why Humacyte, Inc.’s (HUMA) Stock Is Down 6.88%
AAII
Neutral
Why Humacyte, Inc.’s (HUMA) Stock Is Up 5.29%
AAII
Neutral
Wall Street Analysts See Humacyte, Inc. (HUMA) as a Buy: Should You Invest?
Zacks
Neutral
Why Humacyte, Inc.’s (HUMA) Stock Is Down 5.19%
AAII
Neutral

News Score - Last 7 Days

Neutral
HUMA
Sector Average
Media Buzz
This Week2 articles
Weekly Average2 articles
News Sentiment
This Week59%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HUMA’s Media Buzz Sentiment?
2 articles about HUMA were published this week. In an average week, 2 articles are published.
    What is HUMA’s weekly average amount of articles?
    In an average week, 2 articles about HUMA are published.
      What is HUMA’s News Sentiment?
      59% of articles about HUMA were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        DVAXDynavax
        AGIOAgios Pharma
        PDEXPro-Dex
        EWTXEdgewise Therapeutics
        ATAIATAI Life Sciences
        Showing the stocks with the most bullish news sentiment over the past week